Peter Babinec

Prof. Peter Babinec

Comenius University in Bratislava, Faculty of Mathematics, Physics and Informatics, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Bioelectrochemistry
Verified
Journal Article
Closed access
MBMelania Babincova
Melania Babincova
PČP Čičmanec
P Čičmanec
VAV Altanerová
V Altanerová
CACestmir Altaner
Cestmir Altaner
PBPeter Babinec
Peter Babinec

1 January 2001 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
MBMelania Babincova
Melania Babincova
DLDanuta Leszczynska
Danuta Leszczynska
PSPaul Sourivong
Paul Sourivong
PČPavol Čičmanec
Pavol Čičmanec
PBPeter Babinec
Peter Babinec

1 October 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
UAUrsula Altanerova
Ursula Altanerova
MBMelania Babincova
Melania Babincova
PBPeter Babinec
Peter Babinec
KBKatarina Benejova
Katarina Benejova
JJJana Jakubechova
Jana Jakubechova
CACestmir Altaner
Cestmir Altaner
Magnetic hyperthermia, or the heating of tissues using magnetic materials, is a promising approach for treating cancer. We found that human mesenchymal stem cells (MSCs) isolated from various tissues and MSCs expressing the yeast cytosine deaminase::uracil phosphoribosyl transferase suicide fusion gene (yCD::UPRT) can be labeled with Venofer, an iron oxide carbohydrate nanoparticle. Venofer labeling did not affect cell proliferation or the ability to home to tumors. All Venofer-labeled MSCs released exosomes that contained iron oxide. Furthermore, these exosomes were efficiently endocytosed by tumor cells. Exosomes from Venofer-labeled MSCs expressing the yCD::UPRT gene in the presence of the prodrug 5-fluorocytosine inhibited tumor growth in a dose-dependent fashion. The treated tumor cells were also effectively ablated following induction of hyperthermia using an external alternating magnetic field. Cumulatively, we found that magnetic nanoparticles packaged into MSC exosomes are efficiently endocytosed by tumor cells, facilitating targeted tumor cell ablation via magnetically induced hyperthermia.

14 July 2004 in Medical Physics
Verified
Journal Article
Closed access
MBMelania Babincova
Melania Babincova
VAV. Altanerová
V. Altanerová
CACestmir Altaner
Cestmir Altaner
PČP. Čičmanec
P. Čičmanec
PBPeter Babinec
Peter Babinec

1 December 2009 in Biomedical Papers
Verified
Journal Article
Open access
PDF file
MBMelania Babincova
Melania Babincova
PBPeter Babinec
Peter Babinec
Background: Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology. Magnetic nanoparticles for cancer therapy and diagnosis have been developed on the basis of their unique physico-chemical properties not prese...

1 April 2000 in Zeitschrift für Naturforschung C
Verified
Journal Article
Open access
PDF file
MBMelania Babincova
Melania Babincova
VAVeronika Altanerová
Veronika Altanerová
MLMiloš Lampert
Miloš Lampert
CACestmir Altaner
Cestmir Altaner
EMEva Machová
Eva Machová
PBPeter Babinec
Peter Babinec
Human serum albumin labeled with technetium-99m was encapsulated together with magnetite particles into phosphatidylcholine/cholesterol liposomes. In order to investigate the stability of this complex and its ability to be used for magnetic drug targeting, the in-vivo distribution after intravenous administration in rats was estimated. For in-vivo targeting an SmCo permanent magnet with intensity ~ 0.3 5 T was attached near the right kidney. Difference between the relative radioactivity in the magnetically targeted right kidney (25.92±5.84%) and non-targeted left kidney (0.93±0.05%) is sufficiently high for relevant clinical applications.